Intimal deposition of functional von Willebrand factor in atherogenesis.
During the formation of intimal thickening in normocholesterolemic rabbits, von Willebrand factor (vWF) is increased in the endothelial cells (ECs) and deposited in the intima. We investigated whether this also occurs during cholesterol-induced plaque formation, whether the synthesis of vWF increases, and whether this influences platelet adhesion. Rabbits were fed a cholesterol-rich (0.3%) diet for 26 weeks. Thereafter, half of the animals received a normal diet for another 26 weeks (cholesterol withdrawal). To induce intimal thickening in normocholesterolemic rabbits, collars were positioned around the carotid artery. Arterial segments were studied using immunohistochemistry, reverse transcription-polymerase chain reaction, electron microscopy, and platelet adhesion tests. Cholesterol treatment induced plaque formation in the aorta. The ECs had a cuboidal aspect, showed a dense immunoreactivity for vWF, a pronounced rough endoplasmic reticulum, and numerous Weibel-Palade bodies. There were subendothelial vWF deposits in the plaques and vWF mRNA was significantly increased as compared with controls. Similar changes were seen after collar-induced intimal thickening. After cholesterol withdrawal, both vWF mRNA and the ultrastructural morphology of the ECs normalized, and the vWF deposits disappeared from the plaque. Perfusion studies with anticoagulated rabbit blood over cross-sections of atherosclerotic aortas revealed increased vWF-mediated platelet adhesion in the subendothelial plaque region. Whereas rabbit platelets perfused through the lumen adhered to the same extent to de-endothelialized aortas of normocholesterolemic and atherosclerotic rabbits, vWF mediated platelet adhesion to endothelium was observed in atherosclerotic but not in normal aortas. Our results show an increased synthesis and (sub)endothelial presence of vWF after vascular injury, with functional consequences for platelet deposition on the vessel wall.
De Meyer
G R
GR
Division of Pharmacology, University of Antwerp (UIA), Wilrijk, Belgium. gdemeyer@uia.ua.ac.be
Hoylaerts
M F
MF
Kockx
M M
MM
Yamamoto
H
H
Herman
A G
AG
Bult
H
H
D000818:Animals; D001011:Aorta / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D001161:Arteriosclerosis / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology*; D001792:Blood Platelets / Q000166:cytology / Q000502:physiology; D002339:Carotid Arteries / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D002791:Cholesterol, Dietary / Q000494:pharmacology; D008078:Cholesterol, LDL / Q000097:blood; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology; D015870:Gene Expression / Q000502:physiology; D006949:Hyperlipidemias / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology*; D008297:Male; D008854:Microscopy, Electron; D012333:RNA, Messenger / Q000032:analysis; D011817:Rabbits; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014280:Triglycerides / Q000097:blood; D017539:Tunica Intima / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D014841:von Willebrand Factor / Q000235:genetics / Q000378:metabolism*
D002791:Cholesterol, Dietary; D008078:Cholesterol, LDL; D012333:RNA, Messenger; D014280:Triglycerides; D014841:von Willebrand Factor